graft-versus-host disease


Lycera Graduates from Incubator to North Campus Research Complex

Lycera, a biopharmaceutical company and University of Michigan spinoff, plans to partner and collaborate with U-M faculty and students with a move to UM’s North Campus Research Complex.

WWJ Newsradio 950–06/09/2011

(Stock photo)

Prototype Drug Halts Disease That Limits Bone Marrow Transplants

A prototype drug already shown to hold promise for treating autoimmune disorders like lupus, arthritis and psoriasis halts established graft-versus-host disease in mouse models of bone marrow transplantation, research at the University of Michigan and the University of Florida shows


UM Research Shows Promise In Bone Marrow Transplantation

University of Michigan researchers have discovered a new method to prevent the immune-system attacks that often occur following bone marrow transplants. Bone marrow transplantation can cure patients with leukemia and other cancers even when the […]